title: Properties, production, and applications of camelid single-domain antibody fragments.
abstract: Camelids produce functional antibodies devoid of light chains of which the single N-terminal domain is fully capable of antigen binding. These single-domain antibody fragments (VHHs or Nanobodies) have several advantages for biotechnological applications. They are well expressed in microorganisms and have a high stability and solubility. Furthermore, they are well suited for construction of larger molecules and selection systems such as phage, yeast, or ribosome display. This minireview offers an overview of (1) their properties as compared to conventional antibodies, (2) their production in microorganisms, with a focus on yeasts, and (3) their therapeutic applications.
authors: Institute for Animal Science and Health (ID-Lelystad) of Wageningen University and Research Centre, Edelhertweg 15, Lelystad, The Netherlands. michiel.harmsen@wur.nl
authors: M M
authors: MM
authors: Harmsen
authors: H J
authors: HJ
authors: De Haard
mesh_terms: D000818:Animals; D002161:Camelids, New World; D007128:Immunoglobulin Fragments / Q000096:biosynthesis* / Q000627:therapeutic use*; D007143:Immunoglobulin Heavy Chains / Q000096:biosynthesis / Q000627:therapeutic use; D008954:Models, Biological
chemical_list: D007128:Immunoglobulin Fragments; D007143:Immunoglobulin Heavy Chains
references: Nat Methods. 2006 Nov;3(11):887-9
references: 17060912
references: Protein Eng. 1996 Jun;9(6):531-7
references: 8862554
references: Protein Eng. 1993 Nov;6(8):989-95
references: 8309948
references: Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12444-9
references: 15304650
references: Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4586-91
references: 16537393
references: Appl Microbiol Biotechnol. 2006 Oct;72(4):732-7
references: 16636830
references: J Mol Biol. 2004 Jan 2;335(1):49-56
references: 14659739
references: J Immunol Methods. 2006 Aug 31;315(1-2):171-84
references: 16962608
references: Biotechnol Bioeng. 2007 Feb 15;96(3):483-94
references: 16948170
references: Nature. 1993 Jun 3;363(6428):446-8
references: 8502296
references: EMBO J. 2000 Mar 1;19(5):921-30
references: 10698934
references: Immunology. 2003 May;109(1):93-101
references: 12709022
references: J Biol Chem. 2004 Dec 10;279(50):51965-72
references: 15459193
references: Toxicon. 2006 Mar;47(3):364-8
references: 16359717
references: Biochim Biophys Acta. 1999 Apr 12;1431(1):37-46
references: 10209277
references: Biotechnology (N Y). 1995 May;13(5):475-9
references: 9634788
references: Nat Med. 2006 May;12(5):580-4
references: 16604085
references: Curr Opin Biotechnol. 2006 Aug;17(4):341-6
references: 16828275
references: J Virol. 2003 May;77(10):5863-76
references: 12719580
references: J Immunol Methods. 2002 May 1;263(1-2):97-109
references: 12009207
references: J Biotechnol. 2001 Jun;74(4):277-302
references: 11526908
references: Int J Cancer. 2002 Mar 20;98(3):456-62
references: 11920600
references: BMC Biotechnol. 2007 Jan 26;7:7
references: 17257422
references: Adv Protein Chem. 2002;61:119-60
references: 12461823
references: Methods Mol Biol. 2002;178:359-66
references: 11968505
references: Cancer Res. 2004 Apr 15;64(8):2853-7
references: 15087403
references: Nat Biotechnol. 2004 Nov;22(11):1409-14
references: 15529166
references: Nat Rev Drug Discov. 2007 May;6(5):349-56
references: 17431406
references: J Biol Chem. 2001 Mar 9;276(10):7346-50
references: 11053416
references: J Mol Biol. 2003 Sep 19;332(3):643-55
references: 12963373
references: Biochim Biophys Acta. 2003 Dec 5;1624(1-3):21-8
references: 14642809
references: Mol Immunol. 2000 Aug;37(10):579-90
references: 11163394
references: Science. 2006 Sep 8;313(5792):1441-3
references: 16960007
references: Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15130-5
references: 17015837
references: J Mol Biol. 2005 Jul 1;350(1):112-25
references: 15913651
references: Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11346-50
references: 12177434
references: Science. 1967 Aug 11;157(3789):707-9
references: 6028046
references: Biochemistry. 2002 Mar 19;41(11):3628-36
references: 11888279
references: Nat Biotechnol. 2005 Sep;23(9):1126-36
references: 16151406
references: Biochemistry. 2000 Feb 15;39(6):1217-22
references: 10684599
references: Nature. 1995 Mar 9;374(6518):168-73
references: 7877689
references: Nature. 2003 Aug 14;424(6950):783-8
references: 12917687
references: J Immunol Methods. 2003 Oct 1;281(1-2):161-75
references: 14580890
references: Vet Immunol Immunopathol. 2001 Nov;83(1-2):1-9
references: 11604157
references: Nat Struct Biol. 1996 Sep;3(9):752-7
references: 8784347
references: FASEB J. 2002 Feb;16(2):240-2
references: 11772942
references: Clin Vaccine Immunol. 2006 Oct;13(10):1079-86
references: 16928888
references: Vet Microbiol. 2007 Mar 10;120(3-4):193-206
references: 17127019
references: Vaccine. 2005 Sep 30;23(41):4926-34
references: 15992972
references: Vaccine. 2006 May 8;24(19):4130-7
references: 16616802
references: Biochemistry. 1990 Feb 13;29(6):1362-7
references: 2110478
references: Pharm Res. 2004 Jun;21(6):897-903
references: 15212151
references: Bioconjug Chem. 2004 May-Jun;15(3):664-71
references: 15149195
references: J Immunol Methods. 2000 Jun 23;240(1-2):185-95
references: 10854612
references: Nat Struct Biol. 1996 Sep;3(9):803-11
references: 8784355
references: J Biotechnol. 2005 Dec 6;120(4):347-59
references: 16169108
references: EMBO J. 1998 Jul 1;17(13):3512-20
references: 9649422
references: Nature. 1989 Oct 12;341(6242):544-6
references: 2677748
references: Protein Sci. 2002 Mar;11(3):500-15
references: 11847273
references: Nature. 1988 Sep 8;335(6186):188-90
references: 3412476
references: Nat Biotechnol. 2004 Sep;22(9):1161-5
references: 15300256
references: Biochemistry. 2001 Jan 9;40(1):74-83
references: 11141058
references: Mol Immunol. 2006 Feb;43(5):426-35
references: 16337485
references: Cancer Metastasis Rev. 2005 Dec;24(4):501-19
references: 16408159
references: Vet Microbiol. 2005 Nov 30;111(1-2):89-98
references: 16221532
references: Trends Biotechnol. 2006 Nov;24(11):523-9
references: 17000017
references: Adv Drug Deliv Rev. 2006 Aug 7;58(5-6):640-56
references: 16904789
references: Antimicrob Agents Chemother. 2001 Oct;45(10):2807-12
references: 11557473
references: J Infect Dis. 2006 Dec 1;194(11):1580-8
references: 17083044
references: Biochemistry. 1964 Sep;3:1329-38
references: 14229677
references: Protein Eng. 1997 Apr;10(4):435-44
references: 9194169
references: Mol Immunol. 1997 Nov-Dec;34(16-17):1121-31
references: 9566760
references: FASEB J. 2006 Dec;20(14):2636-8
references: 17060401
references: Trends Biochem Sci. 2001 Apr;26(4):230-5
references: 11295555
references: Mol Immunol. 2007 Mar;44(7):1680-90
references: 17011035
references: Arthritis Rheum. 2006 Jun;54(6):1856-66
references: 16736523
references: J Biotechnol. 2000 Jul 14;80(3):261-70
references: 10949316
references: Appl Environ Microbiol. 2005 Jan;71(1):442-50
references: 15640220
references: Appl Environ Microbiol. 2000 Nov;66(11):4940-4
references: 11055947
references: Anal Chem. 2006 Dec 15;78(24):8245-55
references: 17165813
references: Appl Microbiol Biotechnol. 2006 Sep;72(3):544-51
references: 16450109
references: Protein Expr Purif. 2005 Nov;44(1):32-8
references: 15922625
references: Cancer Immunol Immunother. 2007 Mar;56(3):303-317
references: 16738850
references: Biochim Biophys Acta. 2006 Aug;1764(8):1307-19
references: 16872921
references: Protein Eng. 1994 Sep;7(9):1129-35
references: 7831284
references: J Biol Chem. 2004 Jan 9;279(2):1256-61
references: 14527957
references: J Biotechnol. 2000 Feb 28;78(1):11-21
references: 10702907
references: Expert Opin Biol Ther. 2005 Jan;5(1):111-24
references: 15709914
references: J Biol Chem. 2001 Jul 13;276(28):26285-90
references: 11342547
references: Nat Biotechnol. 1997 Jul;15(7):632-6
references: 9219264
references: J Biotechnol. 2005 Aug 22;118(3):270-7
references: 15979755
references: FEBS Lett. 1997 Sep 15;414(3):521-6
references: 9323027